Med Pride
CGMP Deviations; deficiencies observed during FDA inspection
Yes — there is an active recall. 4 ongoing FDA recalls mention Hydrocortisone (70 total). Check the affected lots below.
Most common reason: Sterility / contamination (16 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Hydrocortisone. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
CGMP Deviations; deficiencies observed during FDA inspection
CGMP Deviations; deficiencies observed during FDA inspection
Subpotent Drug
Subpotent Drug
Subpotent Drug
CGMP Deviations
Failed Impurities/Degradation Specifications: Out-of-specification results obtained for related impurities and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.
Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone related impurity and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Lack of sterility assurance
CGMP Deviations: product held outside appropriate storage temperature conditions.
cGMP deviations: Temperature abuse
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
cGMP deficiencies
CGMP Deviations
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
SUBPOTENT DRUG
Lack of Processing Control
Lack of Processing Control
Subpotent Drug: Low Out of specification (OOS) assay results for the hydrocortisone portion of this product.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.